Clinical Trial Update: 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study [NA]

View source ↗

Summary

This completed PET imaging study characterizes the 24-hour time course of striatal D2 receptor occupancy by ziprasidone in schizophrenia and schizoaffective dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED